Table 7.
Regression models to define predictors for sustained remission
Model 1 (parsimonious) | Model 2 | Model 3 | |
---|---|---|---|
DAS28 at baseline | 0.44, 023 to 0.85 | 0.50, 0.21 to 0.85 | 0.42, 0.21 to 0.85 |
Incidental MetS | 0.23, 0.05 to 1.00 | 0.18, 0.04 to 0.89 | 0.23, 0.05 to 1.09 |
Disease duration at baseline | 1.28, 0.94 to 1.74 | 1.26, 0.93 to 1.70 | |
ACCP | 0.20, 0.02 to 2.29 | ||
Age | 0.97, 0.90 to 1.04 |
Data presented as Exp (β), 95% confidence interval. ACCP, antibodies to cyclic citrullinated peptides; DAS28, disease activity score evaluated in 28 joints; MetS, metabolic syndrome.